Chang, Anne Lynn S <br/><br/>
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Feb 2019 
 - 564-566 p.  digital 
<br/><br/> Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2018.08.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Carcinoma, Basal Cell--drug therapy<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Staging<br/>Prognosis<br/>Prospective Studies<br/>Pyridines--therapeutic use<br/>Risk Assessment<br/>Skin Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Outcome